NOAEL Data Cosmetic Ingredient

4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate

Also known as: Methyl N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo(2.2.1)hept-2-ylidene)methyl)anilinium sulphate, Benzenaminium, N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo(2.2.1)hept-2-ylidene)methyl)-, methyl sulfate, EINECS 258-190-8

CAS 52793-97-2

4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate (CAS 52793-97-2) is a chemical substance. Key regulatory status: 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS.

View cosmetic safety profile for Camphor Benzalkonium Methosulfate →

SOURCE noael studies public
NOAEL studies
63
SOURCE chemical inventory jurisdictions
Regulatory lists
1
SOURCE eu clp annex vi
GHS signal
Not classified

Chemical Identity

CAS, identifiers, formula, and alternate names for the matched substance record.

SOURCE DSSTox identifiers 9 fields
Name
4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate
CAS Number
52793-97-2
DTXSID
DTXSID901021735
Molecular Formula
C20H28NO.CH4O3S
InChI Key
BPDGKTMMBDRVHQ-UNVLYCKENA-M
Monoisotopic Mass
394.205205
Synonyms
Methyl N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo(2.2.1)hept-2-ylidene)methyl)anilinium sulphateBenzenaminium, N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo(2.2.1)hept-2-ylidene)methyl)-, methyl sulfateEINECS 258-190-8

Functional Uses

Industrial and product-use categories associated with this substance.

SOURCE EPA CPDat 5 records
BiocideUV stabilizerAnti-static agent

Regulatory Lists

Inventory, screening, and regulatory list matches from public chemical databases.

SOURCE EPA CPDat 1 records
ListKeywordSource
Europe; Personal careEuropean CommissionCosIng

NOAEL Studies

Toxicology endpoints rendered from public NOAEL study rows.

SOURCE NOAEL studies Showing 50 of 63 studies
ValueUnitEndpointRouteSpeciesSource
300mg/kg/day-oralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
300mg/kg/day-oralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
300mg/kg bw/dayLOAELoralratCOSMOS_DB
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=0.819mg/kgNOAELoralratSCCS_vision_codex
=3%NOAELdermal-SCCS_vision_codex
=3%NOAELdermal-SCCS_vision_codex
=3%NOAELdermal-SCCS_vision_codex
=3%NOAELdermal-SCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
=89.1mg/kg bwNOAELoralratSCCS_vision_codex
100mg/kg bw/dayNOAELoralratCOSMOS_DB
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=300mg/kg/dayNOAELoralratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=1000mg/kg/dayNOAEL-ratSCCS_vision_codex
=0.819mg/kgdermal absorptionoralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
=0.819mg/kgdermal absorptionoralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
3%dermal absorptiondermal-UnifiedCodex:SCCS_SHADOW:beta.noael_studies
=89.1mg/kg bwdermal absorptionoralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
=89.1mg/kg bwdermal absorptionoralratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
300mg/kg/daydevelopmental toxicity-guinea pigUnifiedCodex:SCCS_SHADOW:beta.noael_studies
300mg/kg/daydevelopmental toxicity-guinea pigUnifiedCodex:SCCS_SHADOW:beta.noael_studies
1000mg/kg/daydevelopmental toxicity-ratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
1000mg/kg/daydevelopmental toxicity-ratUnifiedCodex:SCCS_SHADOW:beta.noael_studies
1000mg/kg/daydevelopmental toxicity-ratUnifiedCodex:SCCS_SHADOW:beta.noael_studies

Showing 50 of 63 studies

Australian Status (AICIS)

Australian industrial chemicals inventory status and applicable conditions.

SOURCE AICIS inventory 1 records
Inventory Status
listed

SCCS Opinions

EU Scientific Committee opinions tied to the matched substance.

SOURCE EU SCCS 3 opinions
OpinionDateConclusionMax Conc.Concerns
SCCS/1430/1120 September 2011safe with restrictions (addendum revises SCCP/1203/08)3% (revised downward from 6% due to low oral bioavailability concerns)Low oral bioavailability indications via subcutaneous lethality data; addendum requires revised MoS calculation; borderline safety margin at 6% reconsidered
SCCP/1203/0821 January 2009safe with restrictions (later revised by SCCS/1430/11 addendum)3% (as revised); 6% was original conclusion but subsequently correctedBorderline MoS at 3%; low oral bioavailability concern identified post-opinion; adsorption via inhalation not assessed; subsequent addendum (SCCS/1445/11) lowered effective limit
SCCP/0997/0619 December 2006safeup to 6% in sunscreen products (first submission opinion)Borderline MoS; requires new dermal absorption study per SCCNFP guidance before reconsideration; eye irritation noted at 20% aqueous solution

Cosmetic Safety Profile

Same-CAS cosmetic ingredient record for cross-vertical context.

SOURCE CosIng / Ingredients DB
EU Status
restricted
Max
6%
Category
UV Filter
View full cosmetic safety profile →

Frequently Asked Questions

What is the NOAEL for 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate?

4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate has 63 NOAEL studies in the database. The lowest reported value is 0.819 mg/kg via oral in rat. Source: SCCS_vision_codex.

What regulatory lists include 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate?

4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate appears on 1 regulatory/inventory list including Europe; Personal care. Source: EPA CPDat.

Is 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate used in cosmetics?

Yes, 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate is also indexed as a cosmetic ingredient under the name Camphor Benzalkonium Methosulfate. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.

Where does the safety data for 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate come from?

Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.

Is 4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate used outside industrial chemicals?

4-((2-Oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate also appears in cosmetics databases.